Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial

被引：0
|
作者：
Elkins, Jacob [1 ]
Elkind, Mitchell [2 ]
Veltkamp, Roland [3 ]
Montaner, Joan [8 ]
Johnston, S. [6 ]
Singhal, Aneesh [4 ]
Becker, Kyra [7 ]
Lansberg, Maarten [5 ]
Chang, Ih [1 ]
Tang, Weihua [1 ]
Gheuens, Sarah [1 ]
Mehta, Lahar [1 ]
机构：
[1] Biogen, Cambridge, MA USA
[2] Columbia Univ, New York, NY USA
[3] Imperial Coll London, London, England
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[6] Univ Texas, Auston, TX USA
[7] Univ Washington, Seattle, WA 98195 USA
[8] Vall dHebron Res Inst, Barcelona, Spain
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S7.005
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial
    de Ridder, Inger R.
    den Hertog, Heleen M.
    van Gemert, H. Maarten A.
    Schreuder, A. H. C. M. L.
    Ruitenberg, Annemieke
    Maasland, E.
    Saxena, Ritu
    van Tuijl, Jordie H.
    Jansen, Ben P. W.
    Van den Berg-Vos, Renske M.
    Vermeij, Frederique
    Koudstaal, Peter J.
    Kappelle, L. Jaap
    Algra, Ale
    van der Worp, H. Bart
    Dippel, Diederik W. J.
    STROKE, 2017, 48 (04) : 977 - 982
  • [22] Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial
    Stone, Patrick Charles
    Minton, Ollie
    Richardson, Alison
    Buckle, Peter
    Enayat, Zinat E.
    Marston, Louise
    Freemantle, Nick
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (20) : 2382 - 2392
  • [23] Natalizumab treatment for relapsing MS: Further results of a randomized, double-blind, placebo-controlled trial
    Dalton, C
    O'Connor, P
    Rice, G
    Khan, O
    Phillips, JT
    Barker, G
    MacManus, D
    Miszkiel, K
    Miller, D
    NEUROLOGY, 2002, 58 (07) : A167 - A167
  • [24] A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial in Acute Non-Cardioembolic Ischemic Stroke With Adrenomedullin
    Yoshimoto, Takeshi
    Saito, Satoshi
    Omae, Katsuhiro
    Kita, Toshihiro
    Kitamura, Kazuo
    Fukuma, Kazuki
    Washida, Kazuo
    Abe, Soichiro
    Ishiyama, Hiroyuki
    Yamaguchi, Eriko
    Yamagami, Hiroshi
    Kazuy
    Ihara, Masafumi
    STROKE, 2024, 55
  • [25] Fluvastatin in the Therapy of Acute Coronary Syndrome: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Ostadal, Petr
    Alan, David
    Vejvoda, Jiri
    Kukacka, Jiri
    Macek, Milan
    Hajek, Petr
    Mates, Martin
    Kvapil, Milan
    Kettner, Jiri
    Wiendl, Martin
    Aschermann, Ondrej
    Slaby, Josef
    Holm, Frantisek
    Telekes, Peter
    Horak, David
    Blasko, Peter
    Zemanek, David
    Veselka, Josef
    Cepova, Jana
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E101 - E102
  • [26] TALOS: A multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke - ongoing trial
    Kraglund, K. L.
    Andersen, G. A.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 427 - 428
  • [27] FLAME: A Multicenter Randomized Double-Blind Placebo-Controlled Trial with Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke
    Chollet, Francois
    Tardy, Jean
    Albucher, Jean Francois
    Arnaud, Catherine
    Berard, Emilie
    Bejot, Yannick
    Lamy, Catherine
    Jaillard, Assia
    Deltour, Sandrine
    Niclot, Philippe
    Guillon, Benoit
    Moulin, Thierry
    Marque, Phillipe
    Pariente, Jeremie
    Thalamas, Claire
    Loubinoux, Isabella
    NEUROLOGY, 2011, 76 (09) : A666 - A666
  • [28] Adalimumab in Severe and Acute Sciatica A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Genevay, Stephane
    Viatte, Sebastien
    Finckh, Axel
    Zufferey, Pascal
    Balague, Federico
    Gabay, Cem
    ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2339 - 2346
  • [29] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [30] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    NEUROLOGY, 2006, 66 (01) : 88 - 92
12345